Psychedelics

Is ATAI Life Sciences Stock a Buy Right Now?

ATAI Life Sciences NV'is down by 17% year-to-date. Should you buy the dip?

IPO Outlook: LSDI, QSG

The IPOs in focus for the week ahead include psychotropic ingredient outfit Lucy Scientific Discovery and online education specialists QuantaSing Group.

FTHW, NA, SNOW, RSI, PATH: Earnings Preview

This week’s company earnings include Field Trip Health & Wellness (FTHW), National Bank of Canada (NA) Snowflake (SNOW), Rogers Sugar (RSI), and UiPath (PATH).

Best Shroom Stocks to Invest In

Many shroom stocks are attempting to bring magic mushrooms to consumers, but will this trio of psilocybin specialists also bring magic to shareholders?

What is The Shroom Boom?

We take a look into the rising popularity of medicinal mushrooms, including an examination of what’s causing the excitement, what the numbers say and how investors can benefit.

Is Investing in Shroom Stocks a Good Idea?

Shroom stocks, otherwise known as psychedelic stocks, present an early-stage investment opportunity that could result in mainstream health treatments.

Is Atai Life Sciences Stock a Good Investment?

Here we take a look at Atai Life Sciences stock and examine whether the company's stock of alternative and psychedelic treatment candidates makes it a good investment.

What is Life Sciences and Should You Invest?

Investment in Life Sciences has exploded in recent years. But what is Life Sciences? Read on to discover the nature-based opportunities in this field.